| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59000508623dcd0bbdf9c0b263105f1a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate |
2014-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a77157abc34f06b38d1a0e4d342af2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5df71fba974e41c44f3214f7629ab4c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aa9d578ab87ffcfa47c7c04c5b5c4cc |
| publicationDate |
2015-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015044284-A1 |
| titleOfInvention |
Dosage form comprising a steroid 5-alpha-reductase inhibitor and an alpha blocker, process for preparing of a dosage form, use of dosage form, method for the treatment or prophylaxis of a disease or condition mediated by androgen |
| abstract |
The present invention describes new and improved dosage forms containing a steroid 5-alpha-reductase inhibitor, in combination with an alpha blocker, for the treatment or prophylaxis of an androgen mediated disease or condition, preferably for the treatment of benign prostatic hyperplasia (HPB). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10596127-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017058436-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109843272-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11337923-B2 |
| priorityDate |
2013-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |